Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 12Recruiting 4Unknown 3Terminated 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Sleep Initiation and Maintenance Disorders 3Fatigue 2Sleep Wake Disorders 1Prostatic Neoplasms 1Nervous System Diseases 1Neoplasms 1Mental Disorders 1Lymphoma 1Leukemia, Myeloid, Acute 1Dyssomnias 1Cancer Patients 1

Interventions

pembrolizumab 25Cyclophosphamide 20Nivolumab 13Doxorubicin 13Carboplatin 10Surveys and Questionnaires 9Paclitaxel 9Exercise 9atezolizumab 8Vincristine 8Rituximab 8Radiotherapy 8Prednisone 8Dexamethasone 8Bevacizumab 8venetoclax 7fludarabine 7Pemetrexed 7Fluorouracil 7Docetaxel 7Blood Specimen Collection 7lenvatinib 6dostarlimab 6cemiplimab 6budigalimab 6Oxaliplatin 6Cisplatin 6durvalumab 5Leucovorin 5Lenalidomide 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Neoplasms × Cognitive Behavioral Therapy × Clear all
NCT05226078 2025-05-20

The Association Between CBT-I Dose, Sleep Duration, and Fatigue in Breast Cancer Patients

Abramson Cancer Center at Penn Medicine

Phase NA Active not recruiting
64 enrolled

Fatigue, Sleep Initiation and Maintenance Disorders, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡